Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Medicines shortages

Government reforms of Category M reimbursement risk 'exacerbating' drug shortages, says PSNC

The government risks making drugs shortages worse with its generics reimbursement reforms, unless the proposals are rolled out gradually, the Pharmaceutical Services Negotiating Committee (PSNC) has said in its official response to a government consultation.

In July 2019, the Department of Health and Social Care proposed that community pharmacists recoup less money on generics for which a branded version exists and more money from all other Category M drugs.

In its response, the PSNC said the proposals run “a risk of exacerbating problems around drug availability and shortages”, adding that reforms “would need to be made gradually and would need to be carefully monitored to ensure any unintended or detrimental effects are identified”.

The PSNC added that a reduction of the margin on some Category M products “should not increase risk of inequality in distribution of margin amongst contractors” and “should not result in dispensing at a loss for those items”. It said that instead of implementing the proposals, “now would be an appropriate time to revisit discussions regarding the introduction of generic substitution”.

In cases where Category M margins are reduced, the PSNC said the government should consider mitigating losses “by either adding these products to the list of drugs for which discount is not deducted or by applying a reduced level of discount deduction to these products”.

The aim of the consultation, which closes on 17 September 2019, is to ensure that pharmacy contractors are receiving equitable access to the medicines margin.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207063

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Further MCQs in Pharmacy Practice

    Further MCQs in Pharmacy Practice

    Further MCQs in Pharmacy Practice contains 600 practice-oriented pharmacy exam questions. Includes both open- and closed-book sections.

    £30.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.